Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Baxter
McKesson
Dow
Queensland Health
Cantor Fitzgerald
Mallinckrodt
Chubb

Generated: February 15, 2019

DrugPatentWatch Database Preview

Schering Company Profile

« Back to Dashboard

Summary for Schering
International Patents:179
US Patents:6
Tradenames:64
Ingredients:56
NDAs:102
Patent Litigation for Schering: See patent lawsuits for Schering

Drugs and US Patents for Schering

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering QUINORA quinidine sulfate TABLET;ORAL 085222-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up
Schering NETROMYCIN netilmicin sulfate INJECTABLE;INJECTION 050544-003 Feb 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Schering GARAMYCIN gentamicin sulfate INJECTABLE;INJECTION 061716-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Schering

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 6,177,074*PED ➤ Sign Up
Schering NORMOZIDE hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019046-003 Apr 6, 1987 4,066,755 ➤ Sign Up
Schering NORMODYNE labetalol hydrochloride TABLET;ORAL 018687-002 Aug 1, 1984 4,066,755 ➤ Sign Up
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 3,705,233 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SCHERING drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 0.75 mg/mL, 100 mL vial ➤ Subscribe 2009-06-05
➤ Subscribe Delayed-release Tablets 100 mg ➤ Subscribe 2014-06-16
➤ Subscribe Injection 2 mg/mL, 100 mL vial ➤ Subscribe 2008-12-18
➤ Subscribe Oral Suspension 40 mg/mL ➤ Subscribe 2011-02-28
➤ Subscribe Injection 18 mg/mL, 16.7 mL vials ➤ Subscribe 2015-11-24
➤ Subscribe Injection 2 mg/mL, 10 mL vial ➤ Subscribe 2008-09-30

Supplementary Protection Certificates for Schering Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2006 00038 Denmark ➤ Sign Up PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
C0055 France ➤ Sign Up PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
2006 00002 Denmark ➤ Sign Up
0736030/01 Switzerland ➤ Sign Up FORMER OWNER: SCHERING CORPORATION, US
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKinsey
Covington
Baxter
Deloitte
Chubb
Boehringer Ingelheim
Queensland Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.